iShares Neuroscience and Healthcare ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
iShares Neuroscience and Healthcare ETF IBRN
Morningstar’s Analysis IBRN
Will IBRN outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 44.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Praxis Precision Medicines Inc Ordinary Shares | 5.45 | 426,308 | Healthcare |
Dianthus Therapeutics Inc | 5.12 | 400,259 | Healthcare |
ACADIA Pharmaceuticals Inc | 4.82 | 376,461 | Healthcare |
Xenon Pharmaceuticals Inc | 4.67 | 365,148 | Healthcare |
Scholar Rock Holding Corp | 4.51 | 352,212 | Healthcare |
Arrowhead Pharmaceuticals Inc | 4.40 | 344,157 | Healthcare |
Alkermes PLC | 4.35 | 339,722 | Healthcare |
Biogen Inc | 4.06 | 317,028 | Healthcare |
PTC Therapeutics Inc | 3.82 | 298,316 | Healthcare |
Denali Therapeutics Inc | 3.71 | 289,550 | Healthcare |